Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
Topic:Infection
Infections in horses encompass a range of diseases caused by various pathogens, including bacteria, viruses, fungi, and parasites. These infections can affect different systems within the horse, such as the respiratory, gastrointestinal, and integumentary systems, leading to a variety of clinical signs depending on the pathogen and the severity of the infection. Common infectious diseases in horses include equine influenza, strangles, and equine herpesvirus. Diagnosis often involves clinical examination, laboratory testing, and sometimes imaging, to identify the causative agent and assess the extent of the disease. Treatment strategies may include antimicrobial therapy, supportive care, and preventive measures such as vaccination and biosecurity practices. This page aggregates peer-reviewed research studies and scholarly articles that explore the pathogenesis, diagnosis, treatment, and prevention of infectious diseases in equine populations.
Studies on Strongylus asini. I. Experimental infestation of equines. Infective larvae were harvested from a culture of eggs collected from adult Strongylus asini recovered from a free-ranging Burchell's zebra, Equus burchelli, in the Kruger National Park. Worm-free zebra, horse and donkey foals were successfully infested, but infestation failed in a mule foal. At slaughter, 117-125 days post-infestation, S. asini in their 4th moult were recovered from the liver and portal veins. This is the first report of successful experimental infestation of these hosts with S. asini.
Controlled tests of pastes of dichlorvos and thiabendazole against induced Strongyloides westeri infections in pony foals in 1973-1974. In 1973-1974, 4 controlled tests were performed in pony foals (n = 17) raised parasite-free and experimentally infected with Strongyloides westeri. Administration of infective larvae by stomach tube in 1 test resulted in low-grade infections and tended to invalidate the test. Intraoral and percutaneous (intra-aural) administration of larvae resulted in suitable test infections for 1 and 2 tests, respectively. A paste formulation of dichlorvos at 36.3 mg/kg of body weight removal from 4 ponies. Treatment of 4 the dosage rate of 44 mg/kg was consistently effective (greater than 99% to 100%) for ...
Virulence and in vitro growth of a cell-adapted strain of equine infectious anemia virus after serial passage in ponies. Five serial passages of a cell-adapted strain of equine infectious anemia (EIA) virus were conducted in Shetland ponies. The 13 recipient ponies became agar-gel immunodiffusion test-positive by 25 days after they were inoculated. The virulence of the cell-adapted strain of EIA virus markedly increased through 3 serial passages, although individual variation within passages was high. The 1st serial-passage recipient remained afebrile through 200 days, whereas a febrile episode occurred about every 185, 44, 35, and 33 days in the 2nd, 3rd, 4th, and 5th serial-passage recipients, respectively. Se...
Deficiency of interferon-gamma but not interferon-beta in Arabian foals with severe combined immunodeficiency. The results of a study on the induction of IFN-alpha, IFN-beta, and IFN-gamma in normal and SCID foals showed a deficiency of IFN-gamma but not IFN-beta in SCID foals. The ability of SCID mononuclear cells to produce IFN-alpha in response to poly I:C but not to NDV may indicate a partial deficiency of IFN-alpha in SCID foals. The deficiency of IFN-gamma and presence of IFN-beta in SCID foals supports the classification of IFN-gamma and IFN-beta as immune and nonimmune interferons, respectively. Furthermore, the deficiency of IFN-gamma in SCID foals may in part explain the high susceptibility t...
Ivermectin: activity against larval Strongylus vulgaris and adult Trichostrongylus axei in experimental infections in ponies. Activity of ivermectin, administered IM at the dosage rate of 200 micrograms/kg of body weight, was evaluated in controlled tests against migrating larvae of Strongylus vulgaris and adult Trichostrongylus axei in experimental infections in 6 ponies raised worm-free. Ponies were given 2,190 or 2,400 infective 3rd-stage larvae of S vulgaris at 7 days before treatment and 22,000 or 22,750 infective 3rd-stage larvae of T axei at 42 or 45 days before treatment. Three ponies were given ivermectin plus vehicle, and 3 ponies were given the vehicle only; the ponies were euthanatized 7 or 9 days after t...
Irradiated larval vaccination of ponies against strongylus vulgaris. Nonimmune pony foals 9 to 12 mo of age were vaccinated with third-stage Strongylus vulgaris larvae (L3) irradiated with 70, 100, or 130 Kr of gamma radiation. Ponies receiving per os inoculations of L3 irradiated with 70 or 100 Kr were protected from the clinical disease and lesions associated with challenge infections of 4,300 L3, when compared to nonvaccinated controls. Similarly, the numbers of worms from the challenging population recovered from successfully vaccinated animals were significantly lower than from nonvaccinated controls. The degree of resistance that develops in individuals c...
Equine ocular onchocerciasis: histopathologic study. Equine eyes (368) were examined clinically and histologically for abnormalities associated with the presence of ocular microfilariae of naturally occurring Onchocerca sp infection. Forty of the eyes had microfilariae in the conjunctiva, but distinguishing clinical abnormalities were not associated with their presence. In 1 horse with ocular microfilariae that was treated with diethylcarbamazine daily for 2 weeks, ocular tissue samples were obtained before, during, and after the horse was treated, and the samples were compared histologically. During treatment of the horse, microfilariae apparen...
Efficacy of injectable and oral paste formulations of ivermectin against gastrointestinal parasites in ponies. A controlled test was used in ponies to compare the antiparasitic efficacy of ivermectin (22,23-dihydro-avermectin B1) in an injectable micelle solution administered IM with the efficacy of the same drug in an oral paste formulation. Parasite infections were naturally acquired in southern Louisiana. The drug was tested in both formulations at a dosage level of 0.2 mg/kg of body weight. Ivermectin in both formulations tested had an efficacy greater than 98% against Gasterophilus intestinalis and G nasalis larvae. Trichostrongylus axei, Habronema spp, Strongylus vulgaris, S. edentatus, and speci...
Isolation of acholeplasmas from horse feces. Acholeplasmas were detected in five of 96 feces samples from clinically normal horses. Three of the five strains isolated were identified as A. equifetale, one as A. hippikon, and one was serologically identical with the Acholeplasma strain 881.
Equine influenza virus enhances responsiveness of guinea-pig tracheal muscle to isoprenaline. Groups of guinea-pigs were vaccinated with equine influenza A-1 virus and helically-cut tracheal strips were subsequently contracted to carbachol (EC50) and relaxed to isoprenaline at 3, 5 and 10 days post-vaccination. Tracheas from another group were contracted to phenylephrine in the presence of propranolol. Compared to controls, responses to isoprenaline in virus-infected tracheas were significantly potentiated at days 3 and 10. Virus infection significantly inhibited tracheal responsiveness to phenylephrine. It appears that enhancement of isoprenaline may be caused by diminished reactivity...
Lymphocytes from ponies experimentally infected with equine herpesvirus 1: subpopulation dynamics and their response to mitogens. Six pony foals, free of detectable serum neutralization (SN) antibody against equine herpesvirus type 1 by the standard virus-neutralization (VN) test, were inoculated with equine herpesvirus type 1. The ponies showed typical clinical signs of respiratory tract disease and developed a transient leukopenia, involving lymphocytes as well as neutrophils. The leukopenia reached its lowest point on postinoculation days (PID) 3 to 5 and then returned to base-line values by PID 8 to 10. On quantitation of lymphocyte subpopulations, T and B lymphocytes were decreased during the onset of leukopenia and...
Human, bovine, and equine growth hormone antibodies in patients treated with human growth hormone. The immunological behavior of sera from hypopituitary patients treated with human GH (hGH) has been studied by homologous and heterologous RIAs using 125I-labeled hormones. Along with antibodies against hGH, antibodies exhibiting antibovine and antiequine GH (anti-bGH and anti-eGH, respectively) activities were also found. Displacement experiments showed that hGH was an effective competitor of 125 I-labeled hGH, whereas bGH and eGH were quite inefficient. Conversely, when the tracer was 125I-labeled bGH, both bGH and eGH were good displacers, while the human hormone was poor. The values of the...
Actinobacillus suis infection of horses. Nineteen isolates of Actinobacillus suis were recovered from horses during the period October 1978-December 1980. Animals varied in age from a full term foetus to 12 years. One isolate was obtained from the nose of an apparently healthy horse, the remainder were obtained from still-born foetuses (2), foals dying within a week of birth (5), older animals with respiratory (6) or genital infections (3) or abscesses in the jaw (1). One isolate was obtained from the lung of a 2-week-old foal which had shown diarrhoea. The bacteriological characteristics of the isolates and the pathological lesions ...
Clinical observations on equine phycomycosis. During a clinical study of equine phycomycosis in tropical northern Australia 3 specific forms of phycomycosis were identified. Of 266 cases diagnosed in 5 different laboratories, hyphomycosis caused by Hyphomyces destruens was responsible for 76.7%, basidiobolomycosis caused by Basidiobolus haptosporus for 18.0%, and entomophthoramycosis caused by Conidiobolus coronatus for 5.3%. Most cases of hyphomycosis were observed between March and July, that is after the monsoonal wet summer, but were calculated from clinical histories to originate in the wet season between November and May. Basidiobol...
